These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25527013)

  • 1. Novel induction therapies for pleural mesothelioma.
    Donahoe L; Cho J; de Perrot M
    Semin Thorac Cardiovasc Surg; 2014; 26(3):192-200. PubMed ID: 25527013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; Feld R; Leighl NB; Hope A; Waddell TK; Keshavjee S; Cho BC
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):468-73. PubMed ID: 26614413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
    Mordant P; McRae K; Cho J; Keshavjee S; Waddell TK; Feld R; de Perrot M
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):433-8. PubMed ID: 27005976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
    Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma.
    Cho BC; Feld R; Leighl N; Opitz I; Anraku M; Tsao MS; Hwang DM; Hope A; de Perrot M
    J Thorac Oncol; 2014 Mar; 9(3):397-402. PubMed ID: 24445595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
    Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
    Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution.
    Bece A; Tin MM; Martin D; Lin R; McLean J; McCaughan B
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):355-62. PubMed ID: 25753747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction Therapy for Mesothelioma.
    Opitz I; Weder W
    Semin Thorac Cardiovasc Surg; 2015; 27(2):240-9. PubMed ID: 26686455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
    Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
    Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural mesothelioma: is the surgeon still there?
    Opitz I; Weder W
    Ann Oncol; 2018 Aug; 29(8):1710-1717. PubMed ID: 29905765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
    Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
    Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
    Soldera SV; Kavanagh J; Pintilie M; Leighl NB; de Perrot M; Cho J; Hope A; Feld R; Bradbury PA
    Oncologist; 2019 Jul; 24(7):e510-e517. PubMed ID: 30478189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Gomez DR; Hong DS; Allen PK; Welsh JS; Mehran RJ; Tsao AS; Liao Z; Bilton SD; Komaki R; Rice DC
    J Thorac Oncol; 2013 Feb; 8(2):238-45. PubMed ID: 23247629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical management.
    Baud M; Bobbio A; Lococo F; Regnard JF; Alifano M
    Jpn J Clin Oncol; 2014 Nov; 44(11):1127-9. PubMed ID: 25187665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miliary mesothelioma: a new clinical and radiological presentation in mesothelioma patients with prolonged survival after trimodality therapy.
    Purek L; Laroumagne S; Dutau H; Maldonado F; Astoul P
    J Thorac Oncol; 2011 Oct; 6(10):1753-6. PubMed ID: 21918389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.